Medicem International   Report issue

For profit Phase 3 Phase 4
Founded: Prague Czech Republic (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2017
NCT02956785
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Medicem International CR s.r.o.

Active Ingredients

Drugs in Phase 4 Trials (1)

misoprostol (cytotec) (1 trial)

Drugs in Phase 3 Trials (2)

dilapan (1 trial)

dinoprostone (prostin e2) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Congenital Abnormalities (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3